News Results
There are 915,934 News Results
Aug 9, 2019
ALHAMBRA, Calif., Aug. 9, 2019 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed" or the "Company") (NASDAQ: AMEH), an integrated population health management company, announced its consolidated financial results for the...
Aug 9, 2019
NAPERVILLE, Ill., Aug. 9, 2019 /PRNewswire/ -- Track Group, Inc. (OTCQX: TRCK), a global leader in offender tracking and monitoring services, today announced financial results for its third quarter ended...
Aug 14, 2019
NEW YORK, Aug. 14, 2019 /PRNewswire/ -- Ideanomics Inc. (Nasdaq: IDEX) has today announced its 2019 Q2 operating results for the period ended June 30, 2019 (a full copy of...
Aug 14, 2019
MARINA DEL REY, Calif., Aug. 14, 2019 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for...
Sep 4, 2019
Tortoise today announced the following unaudited balance sheet information and asset coverage ratio updates for TYG, NTG, TTP, NDP, TPZ and TEAF. Tortoise Energy Infrastructure Corp. (NYSE: TYG) today announced...
Oct 2, 2019
Tortoise today announced the following unaudited balance sheet information and asset coverage ratio updates for TYG, NTG, TTP, NDP, TPZ and TEAF. Tortoise Energy Infrastructure Corp. (NYSE: TYG) today announced...
Oct 22, 2019
SANTA CLARA, Calif., Oct. 22, 2019 /PRNewswire/ -- In this two-part article, Dr. Khasha Ghaffarzadeh, a leading industry expert and Research Director at IDTechEx, will discuss the global graphene market....
Nov 1, 2019
Texas Pacific Land Trust (NYSE: TPL) today announced financial results for the third quarter ended September 30, 2019. Results for the third quarter of 2019: Net income of $60.0 million,...
Nov 2, 2019
Tortoise today announced the following unaudited balance sheet information and asset coverage ratio updates for TYG, NTG, TTP, NDP, TPZ and TEAF. Tortoise Energy Infrastructure Corp. (NYSE: TYG) today announced...
Nov 7, 2019
SOUTH SAN FRANCISCO, Calif., Nov. 7, 2019 /PRNewswire/ -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for central nervous system (CNS) diseases and disorders with...